1. Home
  2. ARDX vs KW Comparison

ARDX vs KW Comparison

Compare ARDX & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • KW
  • Stock Information
  • Founded
  • ARDX 2007
  • KW 1977
  • Country
  • ARDX United States
  • KW United States
  • Employees
  • ARDX N/A
  • KW N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • KW Real Estate
  • Sector
  • ARDX Health Care
  • KW Finance
  • Exchange
  • ARDX Nasdaq
  • KW Nasdaq
  • Market Cap
  • ARDX 882.9M
  • KW 940.4M
  • IPO Year
  • ARDX 2014
  • KW 1992
  • Fundamental
  • Price
  • ARDX $4.29
  • KW $7.61
  • Analyst Decision
  • ARDX Strong Buy
  • KW Hold
  • Analyst Count
  • ARDX 9
  • KW 1
  • Target Price
  • ARDX $10.17
  • KW $13.00
  • AVG Volume (30 Days)
  • ARDX 4.3M
  • KW 995.6K
  • Earning Date
  • ARDX 08-04-2025
  • KW 08-06-2025
  • Dividend Yield
  • ARDX N/A
  • KW 6.38%
  • EPS Growth
  • ARDX N/A
  • KW N/A
  • EPS
  • ARDX N/A
  • KW N/A
  • Revenue
  • ARDX $361,706,000.00
  • KW $514,600,000.00
  • Revenue This Year
  • ARDX $11.39
  • KW $31.15
  • Revenue Next Year
  • ARDX $32.84
  • KW $3.17
  • P/E Ratio
  • ARDX N/A
  • KW N/A
  • Revenue Growth
  • ARDX 127.33
  • KW N/A
  • 52 Week Low
  • ARDX $3.21
  • KW $5.98
  • 52 Week High
  • ARDX $7.18
  • KW $11.88
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 51.49
  • KW 62.51
  • Support Level
  • ARDX $4.27
  • KW $7.26
  • Resistance Level
  • ARDX $4.48
  • KW $7.67
  • Average True Range (ATR)
  • ARDX 0.19
  • KW 0.20
  • MACD
  • ARDX -0.03
  • KW -0.00
  • Stochastic Oscillator
  • ARDX 15.84
  • KW 61.86

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: